Skip to content

An Efficient Treatment for Posttraumatic Injury for Firefighters

An Efficient Treatment for Posttraumatic Injury for Firefighters

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05950035
Enrollment
49
Registered
2023-07-18
Start date
2023-12-01
Completion date
2025-01-01
Last updated
2025-05-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia, Nightmare, Posttraumatic Stress Disorder

Brief summary

The goal of this two-arm pilot randomized controlled trial is to test a behavioral intervention that integrates three evidence-based cognitive behavioral interventions (written exposure therapy; WET, cognitive behavioral therapy for insomnia; CBT-I, and cognitive behavioral therapy for nightmares; CBT-N) among firefighters. The main questions it aims to answer are: * Is the behavioral intervention feasible, acceptable, and effective in reducing symptoms of posttraumatic stress, insomnia, and nightmares? * What is the efficacy of efficient treatment vs. delayed treatment (2-4 week waitlist) in reducing symptoms of posttraumatic stress, insomnia, and nightmares? We will beta test the intervention in 1-2 groups of 3-5 firefighters. Then we will randomize 50 participants to immediate or delayed (2-4 week waitlist) treatment. Consented participants will: * Complete self-report and interview measures assessing posttraumatic stress disorder, insomnia (PTSD), and nightmares * Attend an individual treatment orientation session * Attend a 4-day (\ 3 hours per day over 4 consecutive days) group treatment that integrates WET, CBT-I, and CBT-N * Attend an individual booster session held approximately one week later * Complete self-report measures before, during, and after treatment, and at a 3-month follow up assessment and a clinical interview before and after treatment to assess program efficacy.

Interventions

WET is a trauma-focused intervention in which individuals write about their worst traumatic experience following scripted instruction from the therapist.

CBTi focuses on stimulus control, eliminating maladaptive coping habits, reducing arousal, and challenging maladaptive thoughts about sleep in an effort to reduce time to fall asleep and time awake during the night.

CBTn involves writing about a distressing or frequent nightmare, rewriting the narrative of the nightmare to target trauma-related themes, and reading the rescripted nightmare narrative.

BEHAVIORALWaitlist

Waitlist for delayed intervention.

Sponsors

University of Arizona
CollaboratorOTHER
Oregon State University
CollaboratorOTHER
Boston University
CollaboratorOTHER
The University of Texas Health Science Center at San Antonio
CollaboratorOTHER
National Development and Research Institutes, Inc.
CollaboratorOTHER
Palo Alto Veterans Institute for Research
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* 18-65 years old * Firefighter * Able to speak and read English * Clinically significant posttraumatic stress symptoms: CAPS-5 total score ≥ 25; ≥ 1 intrusion symptom; ≥ 1 avoidance symptom * Clinically significant symptoms of insomnia: SCISD insomnia criteria are met; ISI ≥ 15 * Clinically significant symptoms of nightmare disorder: SCISD nightmare disorder criteria are met, nightmares ≥ 1 monthly.

Exclusion criteria

* Current suicide or homicide risk meriting crisis intervention * Inability to speak and read English * Inability to comprehend the baseline screening questionnaires * Unwilling to remain abstinent from alcohol during treatment * Serious mental health diagnosis such as bipolar disorder or psychosis.

Design outcomes

Primary

MeasureTime frameDescription
Clinician Administered PTSD Scale (CAPS-5)Change from baseline to post treatment (~4 weeks post baseline)The CAPS-5 is a structured clinical interview that assesses the presence and severity of PTSD symptoms.
Structured Clinical Interview for DSM-5 Sleep Disorders- Revised (SCISD-R)Change from baseline to post treatment (~4 weeks post baseline)The SCISD-R is a semi-structured interview designed to obtain a sleep history and screen for certain sleep disorders and diagnose others, including insomnia, hypersomnia, circadian rhythm sleep-wake disorders, sleep-disordered breathing, and parasomnias.
Insomnia Severity Index (ISI)Change from baseline through 3 months post treatmentThe ISI assesses perceived severity of insomnia.
Nightmare Disorders IndexChange from baseline through 3 months post treatmentThe NDI is a self-report assessment of nightmare disorder.
Posttraumatic Stress Disorder Checklist (PCL-5)Change from baseline through 3 months post treatmentSelf-report measure update of the PCL designed to assess PTSD symptoms as defined by the DSM-5.

Secondary

MeasureTime frameDescription
Trauma-Related Nightmare Survey (TRNS)Change from baseline through 3 months post treatmentThe TRNS assesses nightmare frequency, disturbance, and characteristics.
Net Prompter ScorePost treatment (~4 weeks post baseline)The Net Prompter Score is a single item measures of treatment acceptability that asks respondents to rate the likelihood that they would recommend the efficient treatment to a friend or colleague on a scale from 0-10.
Self-Assessment of Sleep (SASS)Change from baseline through 3 months post treatmentThe SASS is a brief assessment of self-reported sleep quantity and sleep quality.
Sleep Diary and Nightmare LogChange from baseline through post treatment (~4 weeks post baseline)The Sleep Diary and Nightmare Log assess daily subjective sleep patterns and to inform treatment recommendations.
Patient Health Questionnaire-9 (PHQ-9)Change from baseline through 3 months post treatmentThe PHQ-9 the severity of affective and somatic symptoms related to depression; items correspond to the diagnostic criteria for major depression disorder.
Depressive Symptoms Index-Suicidality Subscale (DSI-SS)Change from baseline through 3 months post treatmentThe DSI-SS is a self-report measure of suicidal ideation, plans, perceived control over ideation, and impulses for suicide.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026